Air Liquide Plans Sale of Its Stake in Anios

  Air Liquide Plans Sale of Its Stake in Anios

Business Wire

PARIS -- October 9, 2013

Regulatory News:

Air Liquide (Paris:AI) announces it plans to sell its stake in Laboratoires
Anios, a company that specializes in disinfectant and antiseptic products, in
order to refocus the development of its hygiene business on Schülke, a company
it wholly owns.

In connection with this planned sale, Air Liquide also indicates that it has
received a firm offer from a consortium composed of the Letartre family,
founder of Laboratoires Anios and currently a minority shareholder, and the
investment firm Ardian (formerly AXA Private Equity).

Air Liquide will respond to this offer at the end of the instruction and
consultation process with relevant trade union representatives of personnel
affected by the sale. In addition, the transaction will be subject to the
approval of the French competition authority.

                                     ***

Founded in 1898, Laboratoires Anios has a staff of about 450 employees and
generated revenues of around 180 million euros in 2012.

Air Liquide is the world leader in gases for industry, health and the
environment, and is present in 80countries with close to 50,000employees.
Oxygen, nitrogen, hydrogen and rare gases have been at the core of Air
Liquide’s activities since its creation in 1902. Using these molecules, Air
Liquide continuously reinvents its business, anticipating the needs of current
and future markets. The Group innovates for the good of society while
delivering profitable growth and consistent performance.

Innovative technologies that curb polluting emissions, lower industry’s energy
use, recover and reuse natural resources or develop the energies of tomorrow,
such as hydrogen, biofuels or photovoltaic energy… Oxygen for hospitals, home
healthcare, fighting nosocomial infections… Air Liquide combines many products
and technologies to develop valuable applications and services not only for
its customers but also for society.

A partner for the long term, Air Liquide relies on employee commitment,
customer trust and shareholder support to pursue its vision of sustainable,
competitive growth. The diversity of Air Liquide’s teams, businesses, markets
and geographic presence provides a solid and sustainable base for its
development and strengthens its ability to push back its own limits, conquer
new territories and build its future.

Air Liquide explores the best that air can offer to preserve life, staying
true to its Corporate Social Responsibility and sustainable development
approach. In 2012, the Group’s revenues amounted to €15.3billion of which
82% were generated outside France. AirLiquide is listed on the Paris Euronext
stock exchange (compartment A) and is a member of the CAC 40 and Dow Jones
Euro Stoxx 50 indexes.

Air Liquide Healthcare

Air Liquide Healthcare supplies medical gases, home healthcare services,
hygiene products, medical equipment and specialty ingredients.

In 2012, it served over 7,500hospitals and 1 millionpatients at home
throughout the world.

The Group’s Healthcare business reached € 2,482million in revenues in 2012,
with the support of its 10000employees.

Schülke

Schülke is a hygiene specialist, developing and selling disinfectant,
antiseptic and cleaning products, with a particular focus on hospitals and
doctor’s offices, and industrial preservatives. Founded in Germany in 1889,
the company was acquired by Air Liquide in 1996.

Schülke has approximately 700 employees and its revenues totaled close to 200
million euros in 2012, 60% generated abroad.

                              www.airliquide.com
                    Follow us on Twitter @AirLiquideGroup

Contact:

Air Liquide
Corporate Communications
Anne Bardot, + 33 (0)1 40 62 53 34
or
Anette Rey, + 33 (0)1 40 62 51 31
or
Investor Relations
Virginia Jeanson, +33 (0) 1 40 62 57 37
or
Annie Fournier, +33 (0) 1 40 62 57 18
 
Press spacebar to pause and continue. Press esc to stop.